当前位置: X-MOL 学术Chem. Phys. Lipids › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system.
Chemistry and Physics of Lipids ( IF 3.4 ) Pub Date : 2020-07-01 , DOI: 10.1016/j.chemphyslip.2020.104946
Shabi Parvez 1 , Ganesh Yadagiri 1 , Aakriti Singh 1 , Archana Karole 1 , Om Prakash Singh 2 , Shyam Sundar 3 , Shyam Lal Mudavath 1
Affiliation  

In the current study, we have focused on the design, development and in-vitro evaluation of d-α-tocopheryl polyethylene glycol 1000 succinate modified amphotericin B (AmB) and paromomycin (PM) loaded solid lipid nanoparticles (TPGS-SLNPs) by emulsion-solvent evaporation method. The optimized TPGS-SLNPs had a mean particle size of 199.4 ± 18.9 nm with a polydispersity index of 0.22 ± 0.14 and entrapment efficiency for AmB and PM was found to be 94 ± 1.5 % and 89 ± 0.50 % respectively. The prepared lipid nanoparticles were characterized by Powdered X-ray diffraction study, Fourier transform infrared spectroscopy, Nuclear magnetic resonance spectroscopy to confirm the absence of any interaction between lipids and drugs. The developed formulation showed a sustained drug release over a period of 48 h and were stable at different temperatures. Finally, TPGS-SLNPs (1 μg/mL) was found to significantly (P < 0.001) mitigate the intra-cellular amastigote growth compared to free AmB. The results obtained suggest TPGS-SLNPs could be an efficient carrier for delivering poorly water-soluble drugs and efficiently enhance its therapeutic potential.



中文翻译:

通过在d-α-生育酚聚乙二醇1000琥珀酸酯(TPGS)定制的纳米脂质载体系统中共同递送来提高两性霉素B和巴龙霉素的抗Leishmanial活性。

在当前的研究中,我们专注于d的设计,开发和体外评估-α-生育酚聚乙二醇1000琥珀酸酯修饰的两性霉素B(AmB)和巴龙霉素(PM)负载的固体脂质纳米颗粒(TPGS-SLNPs)通过乳液-溶剂蒸发法制备。优化的TPGS-SLNPs的平均粒径为199.4±18.9 nm,多分散指数为0.22±0.14,AmB和PM的包封效率分别为94±1.5%和89±0.50%。通过粉末X射线衍射研究,傅立叶变换红外光谱,核磁共振光谱对制备的脂质纳米颗粒进行表征,以确认脂质与药物之间不存在任何相互作用。所开发的制剂在48小时内显示出持续的药物释放,并且在不同温度下稳定。最后,发现TPGS-SLNPs(1μg/ mL)显着(P <0。001)与游离AmB相比,可减轻细胞内鞭毛体的生长。所获得的结果表明,TPGS-SLNPs可能是递送水溶性差的药物并有效增强其治疗潜力的有效载体。

更新日期:2020-07-08
down
wechat
bug